of the DOJ inquiry prior to going public, but did not judge that fact to be “material.” Following the Hindenburg report, the Securities and Exchange Commission opened a separate investigation into Clover Health. A Clover Health spokesperson said that neither Clover nor SeekMedicare had been contacted by the DOJ or SEC specifically regarding SeekMedicare.
A spokesperson for SeekMedicare confirmed Walgreens is an investor and that Jared Josleyn, a vice president of innovation at Walgreens, serves as a board observer. The global pharmacy chain did not respond to multiple requests for comment. Josleyn formerly led consumer health strategy and partnerships at Google Health and Verily, Google’s life sciences division. Alphabet’s venture arm GV is also an investor in Clover Health.